Amniotic Fluid

also known as AFED · Amniotic Fluid Eye Drops · pAF

today NCT03583151 · Ph 3

20192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT03583151	May → Dec 2018	tenosynovitis	J&M Shuler	Unknown	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT04281004 Comparator	Jul 2020 → Jan 2023	—	University of Utah	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Amniotic fluid	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03583151 ↗ 1 NCT04281004 ↗
Known as	AFED	“One drop (0.25 mL) of Amniotic Fluid Eye Drops (AFED) in each eye four times daily for seven days” NCT04281004 ↗
Known as	Amniotic Fluid Eye Drops	“One drop (0.25 mL) of Amniotic Fluid Eye Drops (AFED) in each eye four times daily for seven days” NCT04281004 ↗
Known as	pAF	“Purified amniotic fluid (pAF) contains anti-inflammatory, anti-microbial and regenerative factors similar to solid amniotic membrane.” NCT04281004 ↗